Volume 7 Issue 109
Published - 14:00 UTC 08:00 EST 19-Apr-2005 
Next Update - 14:00 UTC 08:00 EST 20-Apr-2005

Editor: Susan K. Boyer, RN
All rights reserved.



Clinical trial of gefitinib for advanced lung cancer closes early

Researchers have closed a randomized clinical trial comparing gefitinib Iressa (TM) vs. placebo following chemotherapy and radiation for patients with non-small cell lung cancer (NSCLC) that had spread only to nearby tissues or lymph nodes. Review of interim data indicated that gefitinib would not improve survival. more  

Alcohol-impaired driving on the increase, study shows

A national survey has found that after a long, slow downward trend alcohol-impaired driving has recently increased significantly. From 1993 to 1997 the estimated annual number of episodes of alcohol-impaired driving (AID) declined at a rate of a little more than one percent per year, from 123 million to 116 million. From 1997 to 1999, however, it increased 37 percent, from 116 million to 159 million. It stayed at that increased rate in 2002. more

Compound from Chinese medicine shows promise in head and neck cancer

A compound derived from cottonseed oil could help improve the effectiveness of chemotherapy at treating head and neck cancer, researchers at the University of Michigan Comprehensive Cancer Center have found. more  

Tea may help prevent diabetes and cataracts

Add another line to the list of benefits from drinking tea: New research in animals suggests that tea may be a simple, inexpensive means of preventing diabetes and its ensuing complications, including cataracts. more

Melbourne researchers develop safer and more effective "aspirin"  

Monash University researchers and staff of the Melbourne-based biotechnology company Cerylid Biosciences Ltd, have discovered and developed a new class of anti-clotting drugs that appears to be more effective than aspirin at preventing disease-causing blood clots and has fewer side effects. more

Patients' lives at risk from substandard drugs say heart specialists 

Global action is needed to counter the dangers of substandard life-saving drugs that are putting patients' lives and health at risk, according to heart specialists writing in the new (19 April) issue of Europe's leading cardiology journal, the European Heart Journal. more

Compounds in plastic packaging act as environmental estrogens altering breast genes

Compounds found in plastic products used to wrap or contain food and beverages have aroused concerns as possible cancer-causing agents because they can sometimes leach out of the plastic and migrate into the food, especially after heating or when the plastic is old or scratched. more


Lung cancer trial closed when data show gefitinib would not improve survival.